Smith & Nephew Pays $240M For Integra’s Extremities Business
Executive Summary
Integra is divesting its underperforming extremity orthopedics product portfolio to focus on its neurosurgery, surgical instrument and regenerative medicine businesses.
You may also be interested in...
Orthopedic Roundup Q4: S&N, Stryker, J&J, Zimmer Biomet See Pandemic-Related Sales Impact
The resurgence of the pandemic during the fourth quarter of 2020 led to slowdown in elective procedures, negatively impacting sales of the four big ortho players.
Market Brief: Extremity Replacement Market Expected To Reach $2Bn By 2024
Despite COVID-19, the market for extremity replacement implants looks healthy in the medium-term, with strong growth predicted as elective surgeries return.
Stryker Sees ‘V-Shape’ Recovery In Third Quarter
Led by the Mako surgical robot, Stryker’s third-quarter sales exceeded Wall Street analysts’ expectations as it prepares to complete the $4bn acquisition of Wright Medical.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: